These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7243690)

  • 1. Pharmacokinetic investigations of Craviten. II. Dose-dependent elimination kinetics in rats following rapid intravenous injection.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):933-9. PubMed ID: 7243690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic investigations of Craviten. IV. First-pass metabolism in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):949-53. PubMed ID: 7243692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic investigations of Craviten. I. Spectrofluorometric determination of the drug in biological material.
    Witek J; Danek A
    Pol J Pharmacol Pharm; 1980; 32(6):927-32. PubMed ID: 7243689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Craviten decomposition in aqueous solutions.
    Kubiak Z; Kuncewicz B; Zurańska M
    Pol J Pharmacol Pharm; 1980; 32(6):917-25. PubMed ID: 7243688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chronic toxicity of the preparation M-71 (Craviten).
    Mach Z; Swierczak J; Pawlik T; Wajdowicz A; Barycz M
    Pol J Pharmacol Pharm; 1980; 32(6):889-91. PubMed ID: 7243685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craviten hydrolysis in plasma in vitro.
    Pogonowska-Wala E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):365-71. PubMed ID: 7322949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical pharmacology of propafenone].
    Ambrosioni E; Marchesini B
    G Ital Cardiol; 1984 Apr; 14(4):285-92. PubMed ID: 6735021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of Craviten (M-71).
    Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
    Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic properties of rithmidazole upon single intravenous introduction].
    Spasov AA; Stepanov AV; Smirnova LA; Petrov VI; Shabasheva IG
    Eksp Klin Farmakol; 2002; 65(3):57-61. PubMed ID: 12227100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of midazolam on pharmacokinetic parameters of procainamide in rabbits.
    Orszulak-Michalak D; Owczarek J; Wiktorowska-Owczarek AK
    Pol J Pharmacol; 2002; 54(2):151-5. PubMed ID: 12139112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding.
    Campos Moreno E; Merino Sanjuán M; Merino V; Nácher A; Martín Algarra RV; Casabó VG
    Eur J Pharm Sci; 2007 Feb; 30(2):190-7. PubMed ID: 17218087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose blood toxicokinetics of methacrylonitrile in the F344 rat.
    Demby KB; Sanchez IM; Ghanayem BI
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):115-21. PubMed ID: 8470115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties.
    Levy RH; Smith GH
    Am J Hosp Pharm; 1973 May; 30(5):398-404. PubMed ID: 4704419
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat.
    Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S
    Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog.
    Grebow P; Feeney W; Johnston M; Lettieri J; Li H; Magnien E; O'Brien P; Swillo R; Weinryb I; Wolf P; Marsiglia JC
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):407-21. PubMed ID: 7268191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the pharmacokinetics of a short-acting antiarrhythmic drug and its effects: studies with Falirytmin.
    Weiss M; Sziegoleit W; Machill K; Hafemeister G; Förster W
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):237-41. PubMed ID: 7450923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.
    Li J; Milne RW; Nation RL; Turnidge JD; Smeaton TC; Coulthard K
    J Antimicrob Chemother; 2004 May; 53(5):837-40. PubMed ID: 15044428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.